Quick Answer
Nautilus Biotechnology, Inc. reported Earnings Per Share Diluted of $0.47 (loss) per share for the year ending 2025.
- Nautilus Biotechnology, Inc. showed an increase of +16.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Nautilus Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Nautilus Biotechnology, Inc.'s Earnings Per Share Diluted has grown by 13.0%.
- Historical annual values: Fiscal year 2025: $0.47 (loss) per share | Fiscal year 2024: $0.56 (loss) per share | Fiscal year 2023: $0.51 (loss) per share | Fiscal year 2022: $0.46 (loss) per share | Fiscal year 2021: $0.60 (loss) per share | Fiscal year 2020: $0.54 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: